Corporate venture capital in Italy: who invests, what to watch

In April 2026 Niulinx, an autonomous-driving spin-off of the Politecnico di Milano, closed a €38 million round. Its two anchors put in €10 million each: A2A, through its venture arm A2A Life Ventures, and CDP Venture Capital, through its artificial intelligence fund. Pirelli and Ferrovie dello Stato Italiane came in alongside them.

Corporate money isn’t a side story in Italy any more. In 2025, says the Venture Capital Monitor (VeM) observatory at LIUC University, corporate investors took part in about a quarter of Italian venture rounds, as lead or co-investor. In the first half of 2026 the share was about 24%. This guide explains what corporate venture capital is, how it differs from a VC fund, who’s investing in Italy right now and which clauses can block your exit later. New to fundraising? Start from the beginner’s map from zero to a first round.

What is corporate venture capital, and how is it different from a VC?

It’s a company taking stakes in startups. Some corporates invest from their own balance sheet through an in-house unit; others back a fund that an independent manager runs. Either way they want two kinds of return. One is financial. The other is strategic: a technology they need, a product they can sell, a market they want to understand. Crunchbase News noted in 2024 that corporations mostly back startups for strategic reasons as well as financial ones.

A venture capital fund is easier to read. It invests money raised from outside investors and is judged on what it hands back to them. If you’re new to how those funds work here, see venture capital in Italy and who invests.

The difference shows in daily dealings. At a VC, the partners decide. At a corporate, the business unit that would use your product usually has a voice too: Eni Next, for one, connects its startups with Eni’s business units for pilots and field tests. Priorities can also move under you. Orrick’s lawyers warn that a strategic investor’s ‘engagement model can shift with reorganisations, leadership changes or industry cycles’.

Corporate venture capital in Italy: the 2026 list

These are the corporate investors in Italy we could confirm as active, from their own pages and recent deal news.

Investor	Behind it	What it backs	Recent activity
Eni Next	Eni	Energy, materials, robotics, fusion, quantum and digital; over $650 million in 23 startups in eight years, about 20% in Italy	Co-led a €550,000 round in EXE Engineering, February 2026
A2A Life Ventures	A2A	Energy transition and circular economy; anchor of 360 Capital’s 360 LIFE II fund (€140 million first closing, €200 million target)	Co-led Niulinx’s €38 million round with CDP Venture Capital, April 2026
Angelini Ventures	Angelini Industries	Biotech, digital health and life sciences in Europe, North America and Israel; €300 million commitment	Co-led RougeTx’s $58 million Series A, 6 October 2026
Neva SGR	Intesa Sanpaolo group	Started as a CVC in 2017; €600 million raised in six funds, €273 million invested in more than 50 companies	Neva II invested in Straiker, August 2026; first exit of Neva II, June 2026
Corporate Partners I	CDP Venture Capital with corporate investors	€300 million in four compartments: Industry Tech, Service Tech, Energy Tech and Infra Tech	Invests from post-seed to Series B; pitches go through CDP’s platform

Each one works differently. Eni Next and Angelini Ventures are in-house units: the money comes from the group, and Eni Next is based in Boston. A2A took another route. It anchored 360 LIFE II, a climate fund run by 360 Capital, with €40 million, alongside De Nora (€10 million) and CDP Venture Capital (€44 million), and it also invests directly, as the Niulinx deal shows.

CDP’s Corporate Partners I pools several companies in one fund. When its compartments opened, the first corporate investors were Adler, Camozzi and Marcegaglia in Industry Tech (2021); BNL BNP Paribas and GPI in Service Tech; and Baker Hughes, Edison, Snam and Italgas in Energy Tech (both 2022). Ferrovie dello Stato added €10 million to Infra Tech in 2023. Our guide explains how CDP Venture Capital funds startups.

The model keeps spreading. In July 2026 Trentino-based Dolomiti Energia subscribed Primo Capital’s Primo Climate fund, with a representative on its advisory board. Some corporates open a door without buying shares: in March 2026 TIM and CDP Venture Capital agreed to validate startups’ technology for industrial use within TIM’s open innovation programme; two CDP portfolio companies, Cubbit and CAEmate, already work with TIM on real use cases.

Outside Italy

Abroad, corporates lead some of the biggest rounds. In September 2025 ASML led Mistral AI’s Series C with €1.3 billion, for about 11% of the company fully diluted, which means counting options as shares. It also got a seat on Mistral’s strategic committee. The two companies signed a long-term agreement, too, to explore AI models across ASML’s products, research and operations. Twelve months on, Samsung Electronics led Mistral’s $3.5 billion Series D. Worldwide, Global Corporate Venturing counted 1,364 corporate-backed rounds in the second quarter of 2026. Together they raised $146 billion.

Strategic investor or VC? Pros and cons for your startup

	What you can gain	What can go wrong
Customers	The corporate can become your first big client: EXE Engineering ran a pilot with Eni before Eni Next invested	Tying the commercial deal to the investment ‘can distort incentives and complicate future financings’ (Orrick)
Credibility	A known name on the cap table, which Orrick calls ‘validation’	If the corporate holds a right on your sale and doesn’t use it, that ‘usually signals to the market that something may be wrong’ (Flesner and Bank)
Know-how	Industry expertise, test sites, commercial relationships	Information can reach a competitor of yours that the corporate also works with
Exit	A shareholder that may one day buy you	Rights to acquire ‘prevent other potential buyers to engage at all’, argue Flesner and Bank
Partners	Access to markets through the group (Orrick)	Exclusivity can ‘forbid the startup to cooperate with the corporation’s competitors’
Staying power	A large balance sheet behind the investment	Strategy shifts with reorganisations and new management (Orrick)

So should you turn a corporate down? Not for these reasons alone. Put a price on the risk instead. MaRS, in its 2019 guide to CVC pitfalls, warns that a lone corporate investor may ‘seek to prevent the startup from working with its competitors’. Its remedy is a syndicate. In practice, that means a financial investor in the round next to the corporate, ideally as lead. Our guide to finding a lead investor for your round shows how.

How to approach a corporate investor

Start with the people who’d use your product, not only with the venture team. MaRS advises corporate investors to secure ‘buy-in from business unit stakeholders relevant to the startup’s solution’. BP Ventures built a network of experts inside BP’s business units, and its managing partner Chad Bown told Global Corporate Venturing in 2023: ‘Our best deal flow now comes internally.’ Find your sponsor in the business first.

Then propose a pilot before anyone talks about shares. EXE Engineering, which automates biogas capture at landfills, went through Zero, the cleantech accelerator of CDP’s network, where Eni is the main partner through its Joule school. It ran a proof of concept with Eni, signed a cooperation agreement with Eni in Africa and, in February 2026, raised €550,000 in a round led by Zero and Eni Next.

The pilot also did part of the work of due diligence, the checks an investor runs before any money moves. By the time Eni Next invested, Eni had already tested the system in a proof of concept.

In your investor pipeline, a corporate needs two names, the venture contact and the business sponsor. Find out early which of the two can say no. Our method for building an investor target list covers the rest. We sell an investor CRM template for €49 (Excel, in English and Italian). It has a fit score for every investor, plus stages, follow-up dates and a dashboard. For a corporate, add one column: the sponsor.

CVC term sheet: the clauses to read twice

A term sheet, the short document that sums up price and terms, looks the same from a corporate as from a fund until you reach the rights tied to a sale. In Global Corporate Venturing’s October 2022 poll of its community, nearly 90% of corporate investors said they had negotiated some special right linked to a portfolio company’s sale.

The most common was information, being told first about a planned deal (38.8%). The right to make the first offer came next, at 18.4%. Rights of first refusal and blocking rights were uncommon. A public LinkedIn version of the same poll got very different answers, so read the figure as a signal, not a census.

• Right of first refusal or right to match on a sale of the company: the corporate can buy on the same terms as any outside offer. Other bidders may not bother if the corporate can match them at the end. A right to be told first costs you far less.
• Exclusivity. A ban on working with the corporate’s competitors can close off much of your market. Limit it by product, territory and time, or refuse it.
• Information rights and board seats. Orrick suggests flagging competitively sensitive data such as pricing, customer data and roadmaps, a redacted board pack for the strategic investor’s director, and recusal when a competitor is on the agenda.
• The commercial contract. Sign it separately, with its own pricing and termination, and avoid cross-defaults that let a supply dispute spill into the investment.
• IP from the pilot. Who owns what you build together? Settle it before the pilot starts.

In an Italian srl these rights end up in the articles of association and the shareholders’ agreement, so read both. For the clauses every investor asks for, see the term sheet clauses that matter at seed.

Checklist: before you take money from a corporate

1. Name the business unit that would buy from you, and one person in it who wants your product.
2. Suggest a pilot. Write down what it covers and when it ends, and agree who’s accountable for the results.
3. Ask who approves the money. The venture team? The business unit? The group’s board?
4. Bring a financial investor into the round so one corporate doesn’t set every term.
5. Strike out or narrow any right of first refusal, right to match or exclusivity.
6. Agree in writing which data the corporate’s director won’t see.
7. Keep the commercial contract separate, with no cross-default to the investment.

This article is general information, not legal or investment advice. Have a lawyer read the investment agreement and any commercial contract with a corporate before you sign.